analyst-supported decision support

Public-CatalogOrbital Risk Review

A documented second look for small and mid-sized LEO operators that need to turn fragmented public orbital data into an internal discussion, a watchlist, and clear follow-up questions.

Base review

$750

One customer-selected LEO spacecraft or tracked object.

Expanded review

$1,250

Up to five related objects or one narrowly agreed orbital region.

Delivery target

5 days

Five business days after payment and receipt of required inputs.

included

A traceable report, not another unexplained score.

Object identity and public-catalog record review

Current orbital-regime and available TLE summary

Source, epoch, retrieval time, and transformation provenance

Data freshness, quality, uncertainty, and status labels

Prioritized watchlist or follow-up checklist

Concise written report and 30-minute analyst readout

One factual correction pass within five business days

required inputs

Start with a defined object and decision.

  1. 1An unambiguous NORAD catalog ID or object identifier
  2. 2The decision, concern, or question motivating the review
  3. 3The relevant time horizon
  4. 4For expanded work, an agreed object list or orbital-region definition

scope boundary

What this review does not do.

Public TLE data and baseline propagation have material limitations. Every conclusion is labeled by evidence state and should be checked against approved operational sources.

Explicit exclusions

  • Real-time tracking or continuous monitoring
  • Operational collision warnings or guaranteed conjunction detection
  • Maneuver recommendations, command authority, or flight-dynamics approval
  • Replacement of approved tracking providers, CDMs, or operator procedures
  • Legal, regulatory, insurance, or launch-safety certification

next step

Tell us which object and decision need review.

We qualify the request first, then send written scope, price, delivery date, proposal expiration, and invoice instructions. Work begins only after payment is confirmed.

Start the inquiry